6683-46-1 1,1,4,4-四甲基-1,2,3,4-四氢萘
词条详情加载中…
分子式C14H20250.6±10.0 °C at 760 mmHg溶解度/溶解性0.00587 mg/ml ; 0.0000312 mol/l 蒸气压/蒸汽压0.0±0.2 mmHg at 25°C 条件: Reflux for 16 h收率: 91%表征数据: 1H NMR (500 MHz, CDCl3) δ 1.33 (s, 12H), 1.74 (s, 4H), 7.16-7.19 (m, 2H), 7.34-7.36 (m, 2H, J = 2 Hz和8.4 Hz);13C NMR (500 MHz, CDCl3) 31.9, 34.2, 35.1, 125.5, 126.5, 144.8参考文献: [1] Patent: US6265423, 2001, B1;[2] Patent: US5344959, 1994, A;[3] Patent: US5475022, 1995, A;[4] Patent: US5130335, 1992, A;[5] Patent: US5149705, 1992, A;[1] Patent: WO2015/188015, 2015, A1;[2] Patent: WO2018/107289, 2018, A1;[3] Journal of the Brazilian Chemical Society, 2018, vol. 29, # 1, p. 109 - 124;[4] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2182 - 2192;[5] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 6, p. 1948 - 1959;[6] Patent: WO2007/5568, 2007, A1;[7] Journal of the American Chemical Society, 1940, vol. 62, p. 36,43;[8] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 9, p. 2352 - 2356;[9] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 13, p. 4740 - 4746;[10] European Journal of Medicinal Chemistry, 2012, vol. 58, p. 346 - 354;[11] Letters in Drug Design and Discovery, 2016, vol. 13, # 8, p. 729 - 733;[12] Patent: US2018/207156, 2018, A1;[13] Patent: US2198374, 1938